Epidemiology of Primary Ophthalmic Inpatient Admissions in the United States

Mustafa Iftikhar, Nadia Junaid, Marili Lemus, Zyannah N. Mallick, Syeda A. Mina, Urooba Hannan, Joseph K. Canner, Asad Latif, Syed Mahmood Ali Shah

Research output: Contribution to journalArticle

Abstract

Purpose To determine the national estimates, demographics, and costs of inpatient eye care in the United States (US). Design Retrospective cross-sectional study. Methods National Inpatient Sample (NIS), a representative sample of all US community hospitals, was used to analyze inpatient admissions with a primary ophthalmic diagnosis from 2001 to 2014. National estimates of the most prevalent diagnoses were determined, and descriptive statistics were calculated for demographics and costs. Results From 2001 to 2014, there were an estimated 671 324 inpatient admissions (male patients, 51.6%; mean [standard deviation] age, 44.5 [27.3] years) in the US owing to an ophthalmic disorder—an annual rate of 16 per 100 000 population. The Mid-Atlantic region had the highest rate. Most admissions were owing to nontraumatic disorders (75.3%), classified as emergencies (41.8%), and covered by public insurance (48.9%). The median length of stay was 2 days and mortality was 0.2%. The total inflation-adjusted cost over the 14-year period was $5.9 billion. The most prevalent diagnosis was orbital cellulitis (14.5%), followed by orbital floor fracture (9.6%) and eyelid abscess (6.0%). Most diagnoses were infectious (28.0%) and the majority were attributed to external disease (24.3%). A total of 31.1% of all patients had an ophthalmic procedure, pars plana vitrectomy (4.8%) being the most common one. Conclusion There were around 48 000 ophthalmic inpatient admissions in the US costing $421 million every year. Orbital pathology, namely infection and trauma, was the leading cause of admissions. Implementing interventions to decrease the incidence of these conditions may significantly reduce the burden of inpatient ophthalmic care.

LanguageEnglish (US)
Pages101-109
Number of pages9
JournalAmerican Journal of Ophthalmology
Volume185
DOIs
StatePublished - Jan 1 2018

Fingerprint

Inpatients
Epidemiology
Costs and Cost Analysis
Mid-Atlantic Region
Orbital Cellulitis
Demography
Orbital Fractures
State Hospitals
Temazepam
Patient Admission
Vitrectomy
Community Hospital
Economic Inflation
Eyelids
Insurance
Abscess
Length of Stay
Emergencies
Cross-Sectional Studies
Pathology

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Iftikhar, M., Junaid, N., Lemus, M., Mallick, Z. N., Mina, S. A., Hannan, U., ... Shah, S. M. A. (2018). Epidemiology of Primary Ophthalmic Inpatient Admissions in the United States. American Journal of Ophthalmology, 185, 101-109. DOI: 10.1016/j.ajo.2017.10.014

Epidemiology of Primary Ophthalmic Inpatient Admissions in the United States. / Iftikhar, Mustafa; Junaid, Nadia; Lemus, Marili; Mallick, Zyannah N.; Mina, Syeda A.; Hannan, Urooba; Canner, Joseph K.; Latif, Asad; Shah, Syed Mahmood Ali.

In: American Journal of Ophthalmology, Vol. 185, 01.01.2018, p. 101-109.

Research output: Contribution to journalArticle

Iftikhar, M, Junaid, N, Lemus, M, Mallick, ZN, Mina, SA, Hannan, U, Canner, JK, Latif, A & Shah, SMA 2018, 'Epidemiology of Primary Ophthalmic Inpatient Admissions in the United States' American Journal of Ophthalmology, vol. 185, pp. 101-109. DOI: 10.1016/j.ajo.2017.10.014
Iftikhar M, Junaid N, Lemus M, Mallick ZN, Mina SA, Hannan U et al. Epidemiology of Primary Ophthalmic Inpatient Admissions in the United States. American Journal of Ophthalmology. 2018 Jan 1;185:101-109. Available from, DOI: 10.1016/j.ajo.2017.10.014
Iftikhar, Mustafa ; Junaid, Nadia ; Lemus, Marili ; Mallick, Zyannah N. ; Mina, Syeda A. ; Hannan, Urooba ; Canner, Joseph K. ; Latif, Asad ; Shah, Syed Mahmood Ali. / Epidemiology of Primary Ophthalmic Inpatient Admissions in the United States. In: American Journal of Ophthalmology. 2018 ; Vol. 185. pp. 101-109
@article{af6bcc235c174e82b35e5f98e70e51ef,
title = "Epidemiology of Primary Ophthalmic Inpatient Admissions in the United States",
abstract = "Purpose To determine the national estimates, demographics, and costs of inpatient eye care in the United States (US). Design Retrospective cross-sectional study. Methods National Inpatient Sample (NIS), a representative sample of all US community hospitals, was used to analyze inpatient admissions with a primary ophthalmic diagnosis from 2001 to 2014. National estimates of the most prevalent diagnoses were determined, and descriptive statistics were calculated for demographics and costs. Results From 2001 to 2014, there were an estimated 671 324 inpatient admissions (male patients, 51.6{\%}; mean [standard deviation] age, 44.5 [27.3] years) in the US owing to an ophthalmic disorder—an annual rate of 16 per 100 000 population. The Mid-Atlantic region had the highest rate. Most admissions were owing to nontraumatic disorders (75.3{\%}), classified as emergencies (41.8{\%}), and covered by public insurance (48.9{\%}). The median length of stay was 2 days and mortality was 0.2{\%}. The total inflation-adjusted cost over the 14-year period was $5.9 billion. The most prevalent diagnosis was orbital cellulitis (14.5{\%}), followed by orbital floor fracture (9.6{\%}) and eyelid abscess (6.0{\%}). Most diagnoses were infectious (28.0{\%}) and the majority were attributed to external disease (24.3{\%}). A total of 31.1{\%} of all patients had an ophthalmic procedure, pars plana vitrectomy (4.8{\%}) being the most common one. Conclusion There were around 48 000 ophthalmic inpatient admissions in the US costing $421 million every year. Orbital pathology, namely infection and trauma, was the leading cause of admissions. Implementing interventions to decrease the incidence of these conditions may significantly reduce the burden of inpatient ophthalmic care.",
author = "Mustafa Iftikhar and Nadia Junaid and Marili Lemus and Mallick, {Zyannah N.} and Mina, {Syeda A.} and Urooba Hannan and Canner, {Joseph K.} and Asad Latif and Shah, {Syed Mahmood Ali}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.ajo.2017.10.014",
language = "English (US)",
volume = "185",
pages = "101--109",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",

}

TY - JOUR

T1 - Epidemiology of Primary Ophthalmic Inpatient Admissions in the United States

AU - Iftikhar,Mustafa

AU - Junaid,Nadia

AU - Lemus,Marili

AU - Mallick,Zyannah N.

AU - Mina,Syeda A.

AU - Hannan,Urooba

AU - Canner,Joseph K.

AU - Latif,Asad

AU - Shah,Syed Mahmood Ali

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Purpose To determine the national estimates, demographics, and costs of inpatient eye care in the United States (US). Design Retrospective cross-sectional study. Methods National Inpatient Sample (NIS), a representative sample of all US community hospitals, was used to analyze inpatient admissions with a primary ophthalmic diagnosis from 2001 to 2014. National estimates of the most prevalent diagnoses were determined, and descriptive statistics were calculated for demographics and costs. Results From 2001 to 2014, there were an estimated 671 324 inpatient admissions (male patients, 51.6%; mean [standard deviation] age, 44.5 [27.3] years) in the US owing to an ophthalmic disorder—an annual rate of 16 per 100 000 population. The Mid-Atlantic region had the highest rate. Most admissions were owing to nontraumatic disorders (75.3%), classified as emergencies (41.8%), and covered by public insurance (48.9%). The median length of stay was 2 days and mortality was 0.2%. The total inflation-adjusted cost over the 14-year period was $5.9 billion. The most prevalent diagnosis was orbital cellulitis (14.5%), followed by orbital floor fracture (9.6%) and eyelid abscess (6.0%). Most diagnoses were infectious (28.0%) and the majority were attributed to external disease (24.3%). A total of 31.1% of all patients had an ophthalmic procedure, pars plana vitrectomy (4.8%) being the most common one. Conclusion There were around 48 000 ophthalmic inpatient admissions in the US costing $421 million every year. Orbital pathology, namely infection and trauma, was the leading cause of admissions. Implementing interventions to decrease the incidence of these conditions may significantly reduce the burden of inpatient ophthalmic care.

AB - Purpose To determine the national estimates, demographics, and costs of inpatient eye care in the United States (US). Design Retrospective cross-sectional study. Methods National Inpatient Sample (NIS), a representative sample of all US community hospitals, was used to analyze inpatient admissions with a primary ophthalmic diagnosis from 2001 to 2014. National estimates of the most prevalent diagnoses were determined, and descriptive statistics were calculated for demographics and costs. Results From 2001 to 2014, there were an estimated 671 324 inpatient admissions (male patients, 51.6%; mean [standard deviation] age, 44.5 [27.3] years) in the US owing to an ophthalmic disorder—an annual rate of 16 per 100 000 population. The Mid-Atlantic region had the highest rate. Most admissions were owing to nontraumatic disorders (75.3%), classified as emergencies (41.8%), and covered by public insurance (48.9%). The median length of stay was 2 days and mortality was 0.2%. The total inflation-adjusted cost over the 14-year period was $5.9 billion. The most prevalent diagnosis was orbital cellulitis (14.5%), followed by orbital floor fracture (9.6%) and eyelid abscess (6.0%). Most diagnoses were infectious (28.0%) and the majority were attributed to external disease (24.3%). A total of 31.1% of all patients had an ophthalmic procedure, pars plana vitrectomy (4.8%) being the most common one. Conclusion There were around 48 000 ophthalmic inpatient admissions in the US costing $421 million every year. Orbital pathology, namely infection and trauma, was the leading cause of admissions. Implementing interventions to decrease the incidence of these conditions may significantly reduce the burden of inpatient ophthalmic care.

UR - http://www.scopus.com/inward/record.url?scp=85034603089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034603089&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2017.10.014

DO - 10.1016/j.ajo.2017.10.014

M3 - Article

VL - 185

SP - 101

EP - 109

JO - American Journal of Ophthalmology

T2 - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

ER -